Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EZHIP and H3K27me3 are useful diagnostic markers for germinoma and for the germinoma component of germ cell tumors of central nervous system.

Neuro-oncology practice·2026
Same author

HOXB13 Is a Sensitive and Specific Diagnostic Marker for Myxopapillary Ependymoma.

The American journal of surgical pathology·2026
Same author

Microglia-astrocyte crosstalk-driven metabolic-inflammatory imbalance and cerebrovascular frailty in exacerbating stroke injury during aging.

Experimental neurology·2026
Same author

Author Correction: Hydrogel dressing integrating FAK inhibition and ROS scavenging for mechano-chemical treatment of atopic dermatitis.

Nature communications·2026
Same author

Combined clustering and association-rule analysis for hospital costs and length of stay in spontaneous intracerebral hemorrhage hospitalizations.

Frontiers in public health·2026
Same author

Trends in MASLD-related cirrhosis and liver cancer across diverse populations, 2010-2023.

Hepatology international·2026

Related Experiment Video

Updated: Jul 17, 2025

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

5.5K

Decrease of 5-hydroxymethylcytosine in primary cutaneous CD4+ small/medium sized pleomorphic T-cell

Jiahui Hu1, Xinyue Zhang1, Lihong Zhao1

  • 1Department of Dermatology, The Second Affiliated Hospital, School of Medicine, Xian Jiaotong University, Xian, China.

Anais Brasileiros De Dermatologia
|September 1, 2023
PubMed
Summary

This study reveals that decreased 5-hydroxymethylcytosine (5-hmC) nuclear staining in CD4+ lymphocytes can help differentiate Primary cutaneous CD4+ small/medium-sized pleomorphic T-Cell lymphoproliferative disorder (PC-SMTLD) from pseudolymphoma (PL). This epigenetic marker aids in diagnosing this challenging dermatological condition.

Keywords:
Cutaneous T-cell lymphomaDNA methylationEpigenomics

More Related Videos

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

11.1K
Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow
08:01

Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow

Published on: November 4, 2016

12.4K

Related Experiment Videos

Last Updated: Jul 17, 2025

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

5.5K
HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

11.1K
Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow
08:01

Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow

Published on: November 4, 2016

12.4K

Area of Science:

  • Dermatology
  • Epigenetics
  • Oncology

Background:

  • Primary cutaneous CD4+ small/medium-sized pleomorphic T-Cell lymphoproliferative disorder (PC-SMTLD) is a controversial dermatological condition often misdiagnosed due to overlap with pseudolymphoma (PL).
  • Epigenetic alterations, specifically DNA methylation and 5-hydroxymethylcytosine (5-hmC) levels, are implicated in lymphomas but understudied in cutaneous lymphomas.
  • Distinguishing PC-SMTLD from PL is clinically challenging, necessitating reliable diagnostic markers.

Purpose of the Study:

  • To investigate the utility of 5-hydroxymethylcytosine (5-hmC) immunostaining in differentiating PC-SMTLD from PL.
  • To assess the role of 5-hmC as a potential biomarker for lymphoproliferative status in cutaneous T-cell disorders.

Main Methods:

  • A retrospective case series involving immunohistochemical and immunofluorescence analysis of 5-hmC in both PC-SMTLD and PL patient samples.
  • Semi-quantitative grading and statistical analysis were employed to compare 5-hmC expression levels between the two groups.
  • Co-staining of 5-hmC with CD4 was performed to evaluate its presence in specific lymphocyte populations.

Main Results:

  • A statistically significant decrease in 5-hmC nuclear staining was observed in PC-SMTLD compared to PL (p < 0.0001).
  • Semi-quantitative integration of 5-hmC scores revealed significant differences between the PC-SMTLD and PL groups.
  • Immunofluorescence confirmed a reduction of 5-hmC within CD4+ lymphocytes in PC-SMTLD cases.

Conclusions:

  • High 5-hmC immunorreactivity in CD4+ lymphocytes is indicative of a benign process, such as PL.
  • Reduced 5-hmC nuclear staining in PC-SMTLD suggests its lymphoproliferative nature and aids in differential diagnosis from PL.
  • 5-hmC immunostaining shows promise as a valuable tool for distinguishing PC-SMTLD from PL, despite the study's small sample size.